DNTH

Dianthus Therapeutics, Inc.NASDAQHealthcare

$86.00+1.70%ClosedMarket Cap: $3.30B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-12	Wedbush	—	Outperform	—
2026-03-10	Baird	—	Outperform	—
2026-03-10	Raymond James	—	Strong Buy	—
2026-03-10	Clear Street	—	Buy	—
2026-03-09	Oppenheimer	—	Outperform	—
2026-03-09	HC Wainwright & Co.	—	Buy	—
2026-03-09	Truist Securities	—	Buy	—
2026-03-04	Guggenheim	—	Buy	—
2026-02-02	Jefferies	—	Buy	—
2026-01-08	Truist Securities	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-4.81	$2.1M	9
Sun Dec 31	$-5.47	$19.0M	11
Mon Dec 31	$-3.70	$203.3M	4
Tue Dec 31	$2.60	$669.3M	4